SAN DIEGO, CA--(Marketwire - Mar 7, 2013) - BioLegend in San Diego, CA, a leading provider of antibodies and reagents for biomedical research, has been granted ISO 9001:2008 certification for ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Feb. 11, 2021, file photo is the exterior of the PerkinElmer lab in Valencia, Calif. PerkinElmer will spend about ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

BioLegend can breathe a bit easier. The San Diego biological research products supplier, which had been cramped for space, opened a new and larger headquarters this week. BioLegend has more than 500 ...

San Diego-based BioLegend Inc., a biotech firm that develops antibodies and reagents used in biomedical research, has broken ground on the second phase of its Sorrento Mesa campus. Scheduled for ...

New Jersey-based drug development services company Covance Inc. (CVD) recently divested its antibody services unit to antibodies and reagents developer and manufacturer BioLegend, Inc. However, ...

The BioLegend Campus Extension started in 2015 with a four-year master plan to privatize a public street and convert the existing 7.5-acre, four-parcel plot into an eight-acre biotechnology campus.

SAN DIEGO--(BUSINESS WIRE)--BioLegend, leading provider of world-class biological reagents and tools that enable life science discovery from research to cure, today announced the opening of its new ...

San Diego-based Biotech firm BioLegend Inc. has begun work on a new campus in Miramar, with an expected project cost of more than $100 million. A company spokeswoman said a ground-breaking was held ...

PerkinElmer, Inc. PKI recently completed its buyout of BioLegend for a total consideration of approximately $5.25 billion. The latest buyout, which is historically the largest for the company, is ...

(Reuters) - Medical diagnostic firm PerkinElmer Inc said on Monday it would buy BioLegend, a privately held maker of reagents and antibodies used in medical research, for about $5.25 billion in a cash ...

BioLegend can breathe a bit easier. The San Diego biological research products supplier, which had been cramped for space, opened a new and larger headquarters this week. BioLegend has more than 500 ...